共 29 条
Antimullerian hormone (AMH) and age as predictors of preimplantation genetic testing for aneuploidies (PGT-A) cycle outcomes and blastocyst quality on day 5 in women undergoing in vitro fertilization (IVF)
被引:4
|作者:
Arnanz, A.
[1
,2
,3
,4
]
Bayram, A.
[1
,2
]
Elkhatib, I.
[1
,2
]
Abdala, A.
[1
,2
]
El-Damen, A.
[1
,2
]
Patel, R.
[1
,2
]
Lawrenz, B.
[1
,2
,5
]
Melado, L.
[1
,2
]
Fatemi, H.
[1
,2
]
De Munck, N.
[6
]
机构:
[1] ART Fertil Clin Abu Dhabi & Dubai, Embryol Lab, Dubai, U Arab Emirates
[2] IVF Clin, Dubai, U Arab Emirates
[3] Univ Alcala de Henares, Biomed & Biotechnol Dept, Madrid, Spain
[4] IVIRMA, Embryol Lab, Madrid, Spain
[5] Womens Univ Hosp Tuebingen, Obstetr Dept, Tubingen, Germany
[6] UZ Brussels, Jette, Belgium
关键词:
PGT-A;
AMH;
Age;
Euploid rate;
Blastocyst quality;
ANTI-MULLERIAN HORMONE;
CONTROLLED OVARIAN STIMULATION;
ANTRAL FOLLICLE COUNT;
EMBRYO QUALITY;
OOCYTE QUALITY;
MLLERIAN HORMONE;
SERUM-LEVELS;
MARKER;
RESERVE;
PREGNANCY;
D O I:
10.1007/s10815-023-02805-z
中图分类号:
Q3 [遗传学];
学科分类号:
071007 ;
090102 ;
摘要:
Purpose The objective of this study was to investigate whether women with diminished ovarian reserve who planned for PGT-A exhibit a lower number of blastocysts for biopsy, ploidy outcomes, and blastocyst quality on day 5, regardless of age. Methods A retrospective analysis was performed between March 2017 and July 2020 at ART Fertility Clinics Abu Dhabi, including couples that were triggered for final oocyte maturation in an ovarian stimulated cycle planned for PGT-A. Patients were stratified into four AMH groups: < 0.65 ng/ml, 0.65-1.29 ng/ml, 1.3-6.25 ng/ml, and > 6.25 ng/ml; four age categories: <= 30, 31-35, 36-40, and > 40 years. Main results and the role of chance A total of 1410 couples with a mean maternal age of 35.2 +/- 6.4 years and AMH of 2.7 +/- 2.6 ng/ml were included. In a multivariate logistic regression analysis, controlling for age, the chance of having at least one blastocyst biopsied/stimulated cycle (1156/1410), the chance of having at least one euploid blastocyst/stimulated cycle (880/1410), and the chance of having one euploid blastocyst once biopsy was performed (880/1156) were affected in all patients with AMH < 0.65 ng/ml [AdjOR 0.18[0.11-0.31] p = 0.008)], [AdjOR 0.18 [0.11-0.29] p < 0.001], and [AdjOR 0.34 [0.19-0.61] p = 0.015] as well as in patients with AMH 0.65-1.29 ng/ml (AdjOR 0.52 [0.32-0.84] p < 0.001), (AdjOR 0.49 [0.33-0.72] p < 0.001), and (AdjOR 0.57 [0.36-0.90] p < 0.001), respectively. In a multivariate linear regression analysis, AMH values did not affect blastocyst quality (- 0.72 [- 1.03 to - 0.41] p < 0.001). Conclusion Irrespective of age, patients with diminished ovarian reserve (AMH < 1.3 ng/ml) have a lower chance of having at least one blastocyst biopsied and lower chance of having at least one euploid blastocyst per ovarian stimulated cycle. Blastocyst quality was not affected by AMH values.
引用
收藏
页码:1467 / 1477
页数:11
相关论文